Exploring the Advantages of a Hydrolyzed Rice Formula in the Dietary Management of Infants with Cow's Milk Allergy in the Middle East, North Africa, and Pakistan Region

Affiliations

28 September 2021

-

doi: 10.3390/nu13103429


Abstract

Cow's milk allergy (CMA) is the most common food allergy in early childhood, and its prevalence continues to rise. Exclusive breastfeeding is recommended for infants in the first 6 months of life, but this recommendation is poorly adhered to in many parts of the world, including the Middle East, North Africa, and Pakistan (MENAP) region. If the infant is affected by CMA, current guidelines recommend extensively hydrolyzed formulas (eHFs) or amino acid-based formulas (AAFs) in the case of severe symptoms, and hydrolyzed rice formulas (HRFs) where available. In recent years, HRFs have been proposed as a plant-based alternative to cow's milk protein-based eHFs, and updates to current guidelines have been recommended. In 2014, a consensus statement and guidelines were published for the Middle East region on the prevention, diagnosis, and management of CMA. As new advances have been made in the extensively hydrolyzed hypoallergenic infant formula space, along with updated scientific evidence, a workshop of experts from the MENAP region focused on HRF was convened in 2021. This publication summarizes the insights from this meeting. During the consensus part of the meeting, a new approach was discussed and approved by all participants, and agreement was reached that HRF can be recommended as a first-line alternative to cow's milk-based eHF in the dietary management of CMA.

Keywords: Middle East; cow’s milk allergy; hydrolyzed protein; infant allergy; infant feeding; rice.

Conflict of interest statement

Yvan Vandenplas has participated as a clinical investigator and/or advisory board member and/or consultant and/or speaker for Abbott Nutrition, BioGaia, By Heart, CHR Hansen, Danone, ELSE Nutrition, Friesland Campina, Mead Johnson Nutrition, Nestle Health Science, Nestle Nutrition Institute, Nutricia, Phathom Pharmaceuticals, United Pharmaceuticals (Novalac) and Wyeth. Christophe Dupont has participated as a clinical investigator and/or advisory board member and/or consultant and/or speaker for Abbott Nutrition, Danone, Nestle Health Science, Nutricia, United Pharmaceuticals (Novalac) and Wyeth, and is shareholder—Table cofounder of DBV Technologies. Mostafa Abdel-Aziz El-Hodhod has participated as a speaker for Abbott Nutrition, Danone, Danone Nutricia, Hero, and Nestle Nutrition Institute. None of the other authors have a conflict of interest. All authors received honoraria for a MENAP experts’ meeting roundtable, held on 9 April 2021.


Similar articles

Hydrolyzed rice formula for dietary management of infants with cow's milk allergy.

Fiocchi A, Barrio-Torres J, Dupont C, Howells HE, Shamir R, Venter C, Meyer R.World Allergy Organ J. 2022 Nov 17;15(12):100717. doi: 10.1016/j.waojou.2022.100717. eCollection 2022 Dec.PMID: 36438193 Free PMC article. Review.

Prevention of Allergic Sensitization and Treatment of Cow's Milk Protein Allergy in Early Life: The Middle-East Step-Down Consensus.

Vandenplas Y, Al-Hussaini B, Al-Mannaei K, Al-Sunaid A, Helmi Ayesh W, El-Degeir M, El-Kabbany N, Haddad J, Hashmi A, Kreishan F, Tawfik E.Nutrients. 2019 Jun 26;11(7):1444. doi: 10.3390/nu11071444.PMID: 31248015 Free PMC article.

A Survey to Identify the Current Management of Cow's Milk Disorders and the Role of Goat Milk-Based Formulas in the Middle East and North Africa Region.

Bahbah WA, ElHodhod M, Salah M, AlRefaee F, AlTuraiki M, Mousa S, Al Mehaidib A, Ayesh WH, El-Bazzar AN, El Haddad J, El Khashab HY, El Zawahry A, Hasosah M, Shaaban SY, Vandenplas Y.Nutrients. 2022 Mar 3;14(5):1067. doi: 10.3390/nu14051067.PMID: 35268042 Free PMC article.

Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey.

Kansu A, Yüce A, Dalgıç B, Şekerel BE, Çullu-Çokuğraş F, Çokuğraş H.Turk J Pediatr. 2016;58(1):1-11. doi: 10.24953/turkjped.2016.01.001.PMID: 27922230

Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.

Osborn DA, Sinn J.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003664. doi: 10.1002/14651858.CD003664.pub3.PMID: 17054180 Updated. Review.


Cited by

Plant-Based Formulas and Liquid Feedings for Infants and Toddlers.

Vandenplas Y, De Mulder N, De Greef E, Huysentruyt K.Nutrients. 2021 Nov 11;13(11):4026. doi: 10.3390/nu13114026.PMID: 34836284 Free PMC article. Review.


KMEL References


References

  1.  
    1. Savage J., Johns C.B. Food allergy: Epidemiology and natural history. Immunol. Allergy Clin. N. Am. 2015;35:45–59. doi: 10.1016/j.iac.2014.09.004. - DOI - PMC - PubMed
  2.  
    1. Prescott S., Allen K.J. Food allergy: Riding the second wave of the allergy epidemic. Pediatr. Allergy Immunol. 2011;22:155–160. doi: 10.1111/j.1399-3038.2011.01145.x. - DOI - PubMed
  3.  
    1. Vandenplas Y., Al-Hussaini B., Al-Mannaei K., Al-Sunaid A., Helmi Ayesh W., El-Degeir M., El-Kabbany N., Haddad J., Hashmi A., Kreishan F., et al. Prevention of allergic sensitization and treatment of cow’s milk protein allergy in early life: The Middle-East step-down consensus. Nutrients. 2019;11:1444. doi: 10.3390/nu11071444. - DOI - PMC - PubMed
  4.  
    1. Australian Society of Clinical Immunology and Allergy Cow’s Milk (Dairy) Allergy. 2019. [(accessed on 15 July 2021)]. Available online: https://www.allergy.org.au/patients/food-allergy/cows-milk-dairy-allergy.
  5.  
    1. Terracciano L., Bouygue G.R., Sarratud T., Veglia F., Martelli A., Fiocchi A. Impact of dietary regimen on the duration of cow’s milk allergy: A random allocation study. Clin. Exp. Allergy. 2010;40:637–642. doi: 10.1111/j.1365-2222.2009.03427.x. - DOI - PubMed
  6.  
    1. Dupont C., Bocquet A., Tome D., Bernard M., Campeotto F., Dumond P., Essex A., Frelut M.L., Guenard-Bilbault L., Lack G., et al. Hydrolyzed rice protein-based formulas, a vegetal alternative in cow’s milk allergy. Nutrients. 2020;12:2654. doi: 10.3390/nu12092654. - DOI - PMC - PubMed
  7.  
    1. Vandenplas Y., Abuabat A., Al-Hammadi S., Aly G.S., Miqdady M.S., Shaaban S.Y., Torbey P.H. Middle East consensus statement on the prevention, diagnosis, and management of cow’s milk protein allergy. Pediatr. Gastroenterol. Hepatol. Nutr. 2014;17:61–73. doi: 10.5223/pghn.2014.17.2.61. - DOI - PMC - PubMed
  8.  
    1. Fiocchi A., Brozek J., Schunemann H., Bahna S.L., von Berg A., Beyer K., Bozzola M., Bradsher J., Compalati E., Ebisawa M., et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. World Allergy Organ. J. 2010;3:57–161. doi: 10.1097/WOX.0b013e3181defeb9. - DOI - PMC - PubMed
  9.  
    1. Bocquet A., Dupont C., Chouraqui J.P., Darmaun D., Feillet F., Frelut M.L., Girardet J.P., Hankard R., Lapillonne A., Roze J.C., et al. Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow’s milk protein allergy. Arch. Pediatr. 2019;26:238–246. doi: 10.1016/j.arcped.2019.03.001. - DOI - PubMed
  10.  
    1. Fiocchi A., Dahda L., Dupont C., Campoy C., Fierro V., Nieto A. Cow’s milk allergy: Towards an update of DRACMA guidelines. World Allergy Organ. J. 2016;9:35. doi: 10.1186/s40413-016-0125-0. - DOI - PMC - PubMed
  11.  
    1. Centers for Disease Control and Prevention Evaluation Research Team Gaining Consensus among Stakeholders through the nominal Group Technique. [(accessed on 14 July 2021)]; Available online: https://www.cdc.gov/healthyyouth/evaluation/pdf/brief7.pdf.